title: [Joint disease in inflammatory bowel disease].
abstract: The joint disorders taxonomically included in the group of seronegative spondyloarthropathies under the generic name of enteropathic arthropathy represent the most frequent extra-intestinal manifestation of inflammatory bowel disease (IBD), affecting 33% of patients. Their frequency is similar to that of ulcerative colitis and Crohn's disease. Enteropathic arthropathy consists of two main joint alterations, peripheral and axial arthritis, as well as a variable group of other peri-articular disorders. Type 1, or pauciarticular, peripheral arthritis generally coincides with IBD exacerbations, while type 2, or polyarticular, peripheral arthritis follows an independent course from IBD. Axial involvement precedes and follows an independent course from IBD and can behave as ankylosing spondylitis or asymptomatic sacroiliitis. The treatment of these rheumatologic disorders is based on the application of general measures and the use of nonsteroidal anti-inflammatory agents; intraarticular corticosteroid administration may eventually become necessary. Sulphasalazine and/or infliximab, which are indicated when the previously mentioned measures fail, can be used to treat both the articular and intestinal diseases simultaneously.
authors.affiliation: Servicio de Medicina Digestiva, Hospital Universitario Dr. Peset, Universidad de Valencia, Valencia, Spain. chemapar@hotmail.com
authors.forename: J M
authors.initials: JM
authors.lastname: Paredes
authors.forename: M M
authors.initials: MM
authors.lastname: Barrachina
authors.forename: J
authors.initials: J
authors.lastname: Román
authors.forename: E
authors.initials: E
authors.lastname: Moreno-Osset
mesh_terms: D001168:Arthritis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D006680:HLA Antigens; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D025241:Spondylarthritis / Q000209:etiology
chemical_list: D006680:HLA Antigens